HK Stock MarketDetailed Quotes

01858 CHUNLI MEDICAL

Watchlist
  • 8.390
  • +0.250+3.07%
Market Closed Nov 7 16:08 CST
3.22BMarket Cap18.32P/E (TTM)

CHUNLI MEDICAL Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
-35.84%508.28M
-29.70%380.13M
-9.95%221.85M
0.58%1.21B
4.24%792.16M
-5.37%540.71M
-4.18%246.36M
8.43%1.2B
5.79%759.96M
18.39%571.39M
Operating income
-35.84%508.28M
-29.70%380.13M
-9.95%221.85M
0.58%1.21B
4.24%792.16M
-5.37%540.71M
-4.18%246.36M
8.43%1.2B
5.79%759.96M
18.39%571.39M
Operating expenses
32.85%-156.04M
27.50%-108.25M
25.51%-58.04M
-15.47%-332.64M
-17.08%-232.37M
-2.55%-149.3M
-55.17%-77.92M
-13.60%-288.08M
-18.58%-198.48M
-28.42%-145.59M
Gross profit
-37.08%352.24M
-30.54%271.88M
-2.75%163.81M
-4.12%875.89M
-0.30%559.78M
-8.08%391.41M
-18.59%168.44M
6.90%913.53M
1.90%561.49M
15.31%425.8M
Selling expenses
30.07%-163.46M
33.20%-111.48M
2.80%-63.15M
2.13%-383.14M
-1.56%-233.75M
-7.66%-166.89M
18.69%-64.97M
-14.45%-391.47M
1.55%-230.17M
-8.68%-155.01M
Administrative expenses
-8.46%-31.36M
-12.41%-21.31M
-6.69%-7.52M
-14.50%-44.47M
-17.15%-28.91M
-22.59%-18.96M
-17.28%-7.05M
-26.63%-38.84M
-15.36%-24.68M
-13.54%-15.46M
Research and development expenses
13.13%-99.68M
9.27%-67.66M
-5.17%-34.99M
3.02%-157.45M
-9.26%-114.74M
-3.16%-74.57M
-0.47%-33.27M
-54.84%-162.34M
-61.11%-105.01M
-111.19%-72.29M
Profit from asset sales
7,237.14%39.21K
--39.21K
----
-84.57%3.9K
-102.17%-549.43
----
----
70.33%25.31K
70.33%25.31K
208.84%25.31K
Revaluation surplus
-14.03%6.08M
6.57%4.67M
-31.73%1.38M
1.27%9.61M
8.14%7.07M
10.60%4.38M
19.29%2.02M
--9.49M
--6.54M
--3.96M
-Changes in the fair value of other assets
-14.03%6.08M
6.57%4.67M
-31.73%1.38M
1.27%9.61M
8.14%7.07M
10.60%4.38M
19.29%2.02M
--9.49M
--6.54M
--3.96M
Impairment and provision
-43.49%-16.47M
7.86%-11.02M
31.10%-5.48M
17.33%-25.02M
14.50%-11.48M
28.70%-11.96M
-58.09%-7.95M
-10.91%-30.27M
-4.13%-13.43M
-63.90%-16.78M
-Other impairment is provision
-43.49%-16.47M
7.86%-11.02M
31.10%-5.48M
17.33%-25.02M
14.50%-11.48M
28.70%-11.96M
-58.09%-7.95M
-10.91%-30.27M
-4.13%-13.43M
-63.90%-16.78M
Special items of operating profit
11.86%16.99M
-11.25%12.5M
10.49%6.02M
13.14%24.82M
-47.15%15.19M
128.98%14.08M
567.34%5.45M
25.68%21.94M
85.95%28.73M
-54.22%6.15M
Operating profit
-68.86%58.37M
-45.10%73.27M
-4.75%58.24M
-6.26%289.39M
-12.73%187.42M
-20.96%133.47M
-26.22%61.14M
-13.75%308.73M
-5.28%214.75M
-4.64%168.86M
Financing cost
-16.81%7.09M
80.47%9.01M
-9.55%1.08M
-17.81%16.58M
-48.62%8.52M
-13.57%4.99M
-14.82%1.2M
109.24%20.17M
94.68%16.58M
8.00%5.78M
Special items of earning before tax
1,530.27%713.98K
909.91%783.77K
819.68%839.1K
-100.87%-69.6K
97.78%-49.92K
103.46%77.61K
91.23%-116.59K
3,843.45%7.97M
-1,295.24%-2.25M
-1,126.43%-2.24M
Earning before tax
-66.22%66.16M
-40.04%83.07M
-3.31%60.16M
-9.19%305.91M
-14.49%195.88M
-19.64%138.54M
-24.99%62.23M
-8.30%336.88M
-2.55%229.07M
-5.41%172.4M
Tax
66.53%-5.16M
67.26%-4.11M
20.53%-5.06M
3.68%-28.09M
20.47%-15.4M
18.57%-12.55M
28.73%-6.36M
35.22%-29.16M
37.32%-19.37M
42.26%-15.41M
After-tax profit from continuing operations
-66.20%61.01M
-37.33%78.96M
-1.35%55.11M
-9.72%277.82M
-13.94%180.48M
-19.75%125.99M
-24.53%55.86M
-4.54%307.72M
2.71%209.71M
0.92%156.98M
Earning after tax
-66.20%61.01M
-37.33%78.96M
-1.35%55.11M
-9.72%277.82M
-13.94%180.48M
-19.75%125.99M
-24.53%55.86M
-4.54%307.72M
2.71%209.71M
0.92%156.98M
Minority profit
-0.29%-142.8K
29.05%-65.18K
---92.55K
---5.9K
---142.39K
---91.88K
----
----
----
----
Profit attributable to shareholders
-66.14%61.15M
-37.32%79.03M
-1.18%55.2M
-9.72%277.82M
-13.87%180.62M
-19.69%126.08M
-24.53%55.86M
-4.54%307.72M
2.71%209.71M
0.92%156.98M
Basic earnings per share
-65.96%0.16
-36.36%0.21
-6.67%0.14
-10.00%0.72
-14.55%0.47
-19.51%0.33
-21.05%0.15
-13.98%0.8
-6.78%0.55
-8.89%0.41
Diluted earnings per share
-65.96%0.16
-36.36%0.21
-6.67%0.14
-10.00%0.72
-14.55%0.47
-19.51%0.33
-21.05%0.15
-13.98%0.8
-6.78%0.55
-8.89%0.41
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover -35.84%508.28M-29.70%380.13M-9.95%221.85M0.58%1.21B4.24%792.16M-5.37%540.71M-4.18%246.36M8.43%1.2B5.79%759.96M18.39%571.39M
Operating income -35.84%508.28M-29.70%380.13M-9.95%221.85M0.58%1.21B4.24%792.16M-5.37%540.71M-4.18%246.36M8.43%1.2B5.79%759.96M18.39%571.39M
Operating expenses 32.85%-156.04M27.50%-108.25M25.51%-58.04M-15.47%-332.64M-17.08%-232.37M-2.55%-149.3M-55.17%-77.92M-13.60%-288.08M-18.58%-198.48M-28.42%-145.59M
Gross profit -37.08%352.24M-30.54%271.88M-2.75%163.81M-4.12%875.89M-0.30%559.78M-8.08%391.41M-18.59%168.44M6.90%913.53M1.90%561.49M15.31%425.8M
Selling expenses 30.07%-163.46M33.20%-111.48M2.80%-63.15M2.13%-383.14M-1.56%-233.75M-7.66%-166.89M18.69%-64.97M-14.45%-391.47M1.55%-230.17M-8.68%-155.01M
Administrative expenses -8.46%-31.36M-12.41%-21.31M-6.69%-7.52M-14.50%-44.47M-17.15%-28.91M-22.59%-18.96M-17.28%-7.05M-26.63%-38.84M-15.36%-24.68M-13.54%-15.46M
Research and development expenses 13.13%-99.68M9.27%-67.66M-5.17%-34.99M3.02%-157.45M-9.26%-114.74M-3.16%-74.57M-0.47%-33.27M-54.84%-162.34M-61.11%-105.01M-111.19%-72.29M
Profit from asset sales 7,237.14%39.21K--39.21K-----84.57%3.9K-102.17%-549.43--------70.33%25.31K70.33%25.31K208.84%25.31K
Revaluation surplus -14.03%6.08M6.57%4.67M-31.73%1.38M1.27%9.61M8.14%7.07M10.60%4.38M19.29%2.02M--9.49M--6.54M--3.96M
-Changes in the fair value of other assets -14.03%6.08M6.57%4.67M-31.73%1.38M1.27%9.61M8.14%7.07M10.60%4.38M19.29%2.02M--9.49M--6.54M--3.96M
Impairment and provision -43.49%-16.47M7.86%-11.02M31.10%-5.48M17.33%-25.02M14.50%-11.48M28.70%-11.96M-58.09%-7.95M-10.91%-30.27M-4.13%-13.43M-63.90%-16.78M
-Other impairment is provision -43.49%-16.47M7.86%-11.02M31.10%-5.48M17.33%-25.02M14.50%-11.48M28.70%-11.96M-58.09%-7.95M-10.91%-30.27M-4.13%-13.43M-63.90%-16.78M
Special items of operating profit 11.86%16.99M-11.25%12.5M10.49%6.02M13.14%24.82M-47.15%15.19M128.98%14.08M567.34%5.45M25.68%21.94M85.95%28.73M-54.22%6.15M
Operating profit -68.86%58.37M-45.10%73.27M-4.75%58.24M-6.26%289.39M-12.73%187.42M-20.96%133.47M-26.22%61.14M-13.75%308.73M-5.28%214.75M-4.64%168.86M
Financing cost -16.81%7.09M80.47%9.01M-9.55%1.08M-17.81%16.58M-48.62%8.52M-13.57%4.99M-14.82%1.2M109.24%20.17M94.68%16.58M8.00%5.78M
Special items of earning before tax 1,530.27%713.98K909.91%783.77K819.68%839.1K-100.87%-69.6K97.78%-49.92K103.46%77.61K91.23%-116.59K3,843.45%7.97M-1,295.24%-2.25M-1,126.43%-2.24M
Earning before tax -66.22%66.16M-40.04%83.07M-3.31%60.16M-9.19%305.91M-14.49%195.88M-19.64%138.54M-24.99%62.23M-8.30%336.88M-2.55%229.07M-5.41%172.4M
Tax 66.53%-5.16M67.26%-4.11M20.53%-5.06M3.68%-28.09M20.47%-15.4M18.57%-12.55M28.73%-6.36M35.22%-29.16M37.32%-19.37M42.26%-15.41M
After-tax profit from continuing operations -66.20%61.01M-37.33%78.96M-1.35%55.11M-9.72%277.82M-13.94%180.48M-19.75%125.99M-24.53%55.86M-4.54%307.72M2.71%209.71M0.92%156.98M
Earning after tax -66.20%61.01M-37.33%78.96M-1.35%55.11M-9.72%277.82M-13.94%180.48M-19.75%125.99M-24.53%55.86M-4.54%307.72M2.71%209.71M0.92%156.98M
Minority profit -0.29%-142.8K29.05%-65.18K---92.55K---5.9K---142.39K---91.88K----------------
Profit attributable to shareholders -66.14%61.15M-37.32%79.03M-1.18%55.2M-9.72%277.82M-13.87%180.62M-19.69%126.08M-24.53%55.86M-4.54%307.72M2.71%209.71M0.92%156.98M
Basic earnings per share -65.96%0.16-36.36%0.21-6.67%0.14-10.00%0.72-14.55%0.47-19.51%0.33-21.05%0.15-13.98%0.8-6.78%0.55-8.89%0.41
Diluted earnings per share -65.96%0.16-36.36%0.21-6.67%0.14-10.00%0.72-14.55%0.47-19.51%0.33-21.05%0.15-13.98%0.8-6.78%0.55-8.89%0.41
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data